BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31183805)

  • 1. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
    Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
    Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study.
    Musarurwa C; Zijenah LS; Mhandire DZ; Bandason T; Mhandire K; Chipiti MM; Munjoma MW; Mujaji WB
    BMC Pulm Med; 2018 May; 18(1):67. PubMed ID: 29739378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth.
    Poowuttikul P; Thomas R; Hart B; Secord E
    J Int Assoc Provid AIDS Care; 2014; 13(5):438-42. PubMed ID: 23881908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
    Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort.
    Vescini F; Cozzi-Lepri A; Borderi M; Re MC; Maggiolo F; De Luca A; Cassola G; Vullo V; Carosi G; Antinori A; Tozzi V; Monforte AD;
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):163-72. PubMed ID: 21826011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of homocysteine, B
    Falasca K; Di Nicola M; Di Martino G; Ucciferri C; Vignale F; Occhionero A; Vecchiet J
    BMC Infect Dis; 2019 Feb; 19(1):105. PubMed ID: 30717694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons.
    Libertone R; Balestra P; Lorenzini P; Pinnetti C; Ricottini M; Menichetti S; Plazzi MM; Giannetti A; Tozzi V; Antinori A; Ammassari A
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19658. PubMed ID: 25394162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D status in perinatally HIV-infected Thai children receiving antiretroviral therapy.
    Aurpibul L; Sricharoenchai S; Wittawatmongkol O; Sirisanthana V; Phongsamart W; Sudjaritruk T; Chokephaibulkit K
    J Pediatr Endocrinol Metab; 2016 Apr; 29(4):407-11. PubMed ID: 26565540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy.
    Cervero M; Agud JL; Torres R; García-Lacalle C; Alcázar V; Jusdado JJ; Moreno S
    HIV Med; 2013 Oct; 14(9):556-62. PubMed ID: 23738846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Gender, Age, Efavirenz Use, and Hypovitaminosis D Among HIV-Infected Adults Living in the Tropics.
    Avihingsanon A; Kerr SJ; Ramautarsing RA; Praditpornsilpa K; Sophonphan J; Ubolyam S; Avihingsanon Y; Khovidhunkit W; Hiransuthikul N; Ruxrungtham K
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):317-24. PubMed ID: 26413903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York.
    Kwan CK; Eckhardt B; Baghdadi J; Aberg JA
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1025-32. PubMed ID: 22220755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy.
    Avihingsanon A; Apornpong T; Ramautarsing RA; Ubolyam S; Tangkijvanich P; Ananworanich J; Lange JM; Matthews G; Lewin SR; Ruxrungtham K;
    Antivir Ther; 2014; 19(1):41-9. PubMed ID: 23970149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting.
    Wiboonchutikul S; Sungkanuparph S; Kiertiburanakul S; Chailurkit LO; Charoenyingwattana A; Wangsomboonsiri W; Chantratita W; Ongphiphadhanakul B
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):305-10. PubMed ID: 22247338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients.
    Theodorou M; Sersté T; Van Gossum M; Dewit S
    Clin Nutr; 2014 Apr; 33(2):274-9. PubMed ID: 23680190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive disorders in HIV-infected patients: are they HIV-related?
    Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
    AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIV.
    Mastrorosa I; Pinnetti C; Brita AC; Mondi A; Lorenzini P; Del Duca G; Vergori A; Mazzotta V; Gagliardini R; Camici M; De Zottis F; Fusto M; Plazzi MM; Grilli E; Bellagamba R; Cicalini S; Antinori A
    Clin Infect Dis; 2023 Feb; 76(3):e629-e637. PubMed ID: 35982541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.
    Evering TH; Applebaum A; La Mar M; Garmon D; Dorfman D; Markowitz M
    AIDS; 2016 Jan; 30(2):203-10. PubMed ID: 26684817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
    Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
    AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
    Legeai C; Vigouroux C; Souberbielle JC; Bouchaud O; Boufassa F; Bastard JP; Carlier R; Capeau J; Goujard C; Meyer L; Viard JP;
    PLoS One; 2013; 8(9):e74868. PubMed ID: 24058636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study.
    Calza L; di Pietro G; Colangeli V; Borderi M; Zaghi I; Malosso P; Bon I; Re MC; Viale P
    New Microbiol; 2019 Jul; 42(3):145-149. PubMed ID: 31305932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.